Predict your next investment

Corporation
primexpharma.com

See what CB Insights has to offer

Partners & Customers

1

About Primex Pharmaceuticals

Primex Pharmaceuticals is a specialty pharmaceutical company that supplies world-class products and brands in the areas of cardiology, anesthesia, oncology, and intensive care to healthcare institutions and professionals around the world.

Primex Pharmaceuticals Headquarter Location

Obmoos 4

Zug, CH-6300,

Switzerland

+41 796 162 694

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Primex Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Primex Pharmaceuticals in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Primex Pharmaceuticals News

Dental Anesthetics Market to See Huge Growth by 2029 | Companies Septodont Group, Dentsply Sirona, Inc., Primex Pharmaceuticals Ltd.

Jan 18, 2021

| Companies Septodont Group, Dentsply Sirona, Inc., Primex Pharmaceuticals Ltd. Witnessing an average Y-o-Y growth of ~5% in the revenues, the global dental anesthetics market is set to reach the US$ 1 billion market, by 2020. Hospitals will remain the cornerstone of the promising growth outlook of dental anesthetics market, according to a recent study of Fact.MR. The report suggests that half of the overall sales of dental anesthetics is accounted by hospital pharmacies, whereas a third of the total dental anesthetics consumption is registered by hospitals. A Meaningful evolution of the dentistry and healthcare industry in recent years has provided a feasible boost to dental anesthetics, thereby driving developments in the market. Dental consumables industry is growing positively in line with the progressing traction and outgrowing dental anesthetics market, over the recent past. The current growth trend of dental anesthetics market has prominently influenced the increasing number of dental patients across all the regions of the globe, says the report. To remain ‘ahead’ of your competitors, request for a sample>>>  https://www.factmr.com/connectus/sample?flag=S&rep_id=3552 The study opines that although the increasing consumer awareness about oral care and dental treatments will push the growth of dental anesthetics market, the development of oral care and dentistry offers a potential boost to dental anesthetics sales owing to the rising demand from patients for painless operations. Dental anesthetics has steadily gained widespread acceptance as a safe and effective minimally invasive procedure. Healthcare providers around the globe have opted for dental anesthetics as a preferred option while treating a wide range of injuries and disorders. Dental anesthetics have witnessed several advancements in terms of technology to achieve higher precision and reduce pain during surgeries and operations. There are numerous aspects that have triggered the adoption of dental care thus pushing the growth of the dental anesthetics market. Increasing spending on dental treatments owing to higher disposable income of individuals worldwide coupled with increasing awareness about oral health have positively impacted the global market growth. Fact.MR’s analysis also analyzes how dental tourism is on a constant rise and becoming an increasingly important aspect fueling the growth of dental anesthetics market. Cost-efficient dental procedures and new dental technologies will continue to create new growth opportunities. Increasing coverage of commercial insurance and Medicaid represents the powerful tailwind in the entire dental care market. Private health insurance coverage lowers the out of pocket expenses by nearly 80%. For example, the Patient Protection and Affordable Care Act of 2010, is expected to increase the number of individuals with dental benefits by providing consumers with information that would help them better understand the various options and various choices of plans available to them. It will thus create a more organized and competitive market for health insurance by setting common rules regarding the offering and pricing of insurance. Market in Europe & APAC Projected for Lucrative Prospects Fact.MR’s study envisions dental anesthetics market to exhibit significant growth rate during the forecast period. The average per capita spending over oral care and healthcare by North America is slightly more than that of Europe and other regions across the globe, which is likely to boost the growth of dental anesthetics market. North America’s continued primacy in dental anesthetics market is likely to prevail, followed by Europe. The growth of latter is likely to be driven by mounting R&D investments in dental care space, within countries, such as the UK and Germany. Dental anesthetics are largely being manufactured in Europe, out of which a large percentage is being exported to other regions, according to Fact.MR’s research. Latin America is a potential market for dental products after United States. Brazil market for dental anesthetics is expanding at a constant rate owing to entry of various international players. However, counties like Mexico and Brazil import a range of dental anesthetics from Europe and US on a large scale. On the other side, Asia Pacific holds lucrative opportunistic potential for the dental anesthetics market, banking on the easy labor availability and relatively lower land costs. Companies are thus strategizing the establishment of their manufacturing bases in Asian economies. Moreover, fast-developing economies, such as China and India, have showcased a notable increase in dental surgeries over the recent past, which continues to trigger increased usage of dental anesthetics in this region. This Fact.MR study tracks the growth of global dental anesthetics market over a decade-old projection period, 2019-2029. About Us Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions. Contact Us Jumeirah Lakes Towers, Dubai, United Arab Emirates Ph. No: +353-1-6111-593

Primex Pharmaceuticals Acquisitions

2 Acquisitions

Primex Pharmaceuticals acquired 2 companies. Their latest acquisition was OGNA Pharmaceuticals on November 22, 2016.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/22/2016

Acquired

1

2/23/2016

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/22/2016

2/23/2016

Investment Stage

Companies

Subscribe to see more

Valuation

Total Funding

$99M

Note

Acquired

Subscribe to see more

Sources

1

10

Primex Pharmaceuticals Partners & Customers

1 Partners and customers

Primex Pharmaceuticals has 1 strategic partners and customers. Primex Pharmaceuticals recently partnered with POA Pharma on February 2, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

2/21/2019

Partner

POA Pharma

Sweden

Primex Pharmaceuticals and POA Pharma sign a strategic partnership to commercialise OZALIN in the Nordic region

Gothenberg and Zug , 21st February 2019 -- POA Pharma , a market-oriented Boutique Healthcare Company , working in close contact with healthcare organizations , professionals and Hospitals in Nordic countries and Primex Pharmaceuticals , an innovative Anaesthesia pharmaceutical company , today announced a strategic agreement to launch OZALIN ® in Denmark , Finland , Norway and Sweden .

1

Date

2/21/2019

Type

Partner

Business Partner

POA Pharma

Country

Sweden

News Snippet

Primex Pharmaceuticals and POA Pharma sign a strategic partnership to commercialise OZALIN in the Nordic region

Gothenberg and Zug , 21st February 2019 -- POA Pharma , a market-oriented Boutique Healthcare Company , working in close contact with healthcare organizations , professionals and Hospitals in Nordic countries and Primex Pharmaceuticals , an innovative Anaesthesia pharmaceutical company , today announced a strategic agreement to launch OZALIN ® in Denmark , Finland , Norway and Sweden .

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.